Endothelin-1 Receptor Blockade in Resistant Hypertension

NCT04388124 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Resistant Hypertension

Interventions

DRUG: Bosentan
DRUG: Placebo

Sponsor

University Hospital, Rouen